Foresite Capital Management V, LLC Adagio Therapeutics, Inc. Transaction History

Foresite Capital Management V, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.81 - $10.77 $1.19 Million - $3.37 Million	-313,234 Reduced 17.95%	1,431,826 $6.53 Million
Q4 2021 Feb 11, 2022	BUY	$6.35 - $47.04 $2.95 Million - $21.8 Million	464,420 Added 36.26%	1,745,060 $12.7 Million
Q3 2021 Nov 12, 2021	BUY	$20.88 - $56.08 $26.7 Million - $71.8 Million	1,280,640 New	1,280,640 $54.1 Million

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management V, LLC with notifications on news.